ConductScience.org, home

Paper3999028

Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.

Hammarlund MM and 2 others. J Pharmacol Exp Ther, 1985. Cited by 118 papers, by iCite.

Cite this record

ConductScience Library. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling. Papers, record 3999028. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3999028

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
118
iCite
Relative citation ratio, by iCite
6.35
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hammarlund MMM M
2Odlind BB
3Paalzow LKL K

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DiuresisMajor topic
FurosemideMajor topic
Adult
Chlorides
Drug Tolerance
Female
Humans
Kinetics
Male
Models, Biological

Source PubMed

Download CSV of topics

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.

PMIDTitleJournalYearIn PapersSource
40895968Comparative Renal Effects of Continuous Infusion Versus Intermittent Bolus Dosing of IV Loop Diuretics in Acute Decompensated Heart Failure: A Meta-Analysis.Cureus2025https://conductscience.org/library/papers/40895968PubMed
36909062Continuous Infusion Versus Bolus Injection of Loop Diuretics for Patients With Congestive Heart Failure: A Meta-Analysis.Cureus2023https://conductscience.org/library/papers/36909062PubMed
36839862Interplay of Breast Cancer Resistance Protein (Bcrp/Abcg2), Sex, and Fed State in Oral Pharmacokinetic Variability of Furosemide in Rats.Pharmaceutics2023https://conductscience.org/library/papers/36839862PubMed
34529790Renal sodium avidity, the prevailing renal target in heart failure.Eur Heart J2021https://conductscience.org/library/papers/34529790PubMed
34529781Compensatory post-diuretic renal sodium reabsorption is not a dominant mechanism of diuretic resistance in acute heart failure.Eur Heart J2021https://conductscience.org/library/papers/34529781PubMed
32095456Hydrochlorothiazide does not increase furosemide's effects in end-stage renal disease.Transl Clin Pharmacol2017https://conductscience.org/library/papers/32095456PubMed
30802242A computational model of epithelial solute and water transport along a human nephron.PLoS Comput Biol2019https://conductscience.org/library/papers/30802242PubMed
30054781Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis.Heart Fail Rev2019https://conductscience.org/library/papers/30054781PubMed
29031573Aerosol furosemide for dyspnea: Controlled delivery does not improve effectiveness.Respir Physiol Neurobiol2018https://conductscience.org/library/papers/29031573PubMed
24735761Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.J Pharm Pharm Sci2014https://conductscience.org/library/papers/24735761PubMed
24276421Clinical pharmacology of furosemide in neonates: a review.Pharmaceuticals (Basel)2013https://conductscience.org/library/papers/24276421PubMed
18925386Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A.Naunyn Schmiedebergs Arch Pharmacol2009https://conductscience.org/library/papers/18925386PubMed
17441933Absence of tolerance and toxicity to high-dose continuous intravenous furosemide in haemodynamically unstable infants after cardiac surgery.Br J Clin Pharmacol2007https://conductscience.org/library/papers/17441933PubMed
16404503Pharmacokinetic-pharmacodynamic modelling: history and perspectives.J Pharmacokinet Pharmacodyn2006https://conductscience.org/library/papers/16404503PubMed
16034890Continuous infusion versus bolus injection of loop diuretics in congestive heart failure.Cochrane Database Syst Rev2005https://conductscience.org/library/papers/16034890PubMed
10510147The influence of frusemide formulation on diuretic effect and efficiency.Br J Clin Pharmacol1999https://conductscience.org/library/papers/10510147PubMed
10384860The efficiency concept in pharmacodynamics.Clin Pharmacokinet1999https://conductscience.org/library/papers/10384860PubMed
10092960Interchangeability and predictive performance of empirical tolerance models.Clin Pharmacokinet1999https://conductscience.org/library/papers/10092960PubMed
9833602The influence of drug input rate on the development of tolerance to frusemide.Br J Clin Pharmacol1998https://conductscience.org/library/papers/9833602PubMed
9739481Methodological issues in pharmacokinetic-pharmacodynamic modelling.Clin Pharmacokinet1998https://conductscience.org/library/papers/9739481PubMed

See all 45 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3999028

GET https://conductscience.org/api/papers/v1/3999028/cited_by?page=2